Although RSV often presents initially with common cold-like symptoms, it can progress to more severe respiratory problems.

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

“Watched my baby with a tube down his throat for eight days and wasn’t sure if I was ever going to hold him again,” Elliot’s ...

From today, February 3, pregnant women in Australia will be eligible for a free RSV vaccine under the National Immunisation ...

Those most at risk from RSV include babies under 6 months old, young children who were born prematurely, and adults over ...

A new NHS text message campaign is set to encourage RSV vaccinations. Starting on February 10, the campaign targets those ...

The NHS is urging around 1.3 million older people who have not yet had the respiratory syncytial virus vaccine to get jabbed, as health service chiefs warn it is “not just a winter illness”. Invites ...

NHS England appeals for 1.3 million eligible people to come forward for a new jab against respiratory syncytial virus (RSV) ...

MORE than one million people in England are being urged to get a life-saving new vaccine. It protects against respiratory syncytial virus (RSV) – a cold-like illness that can make some ...

More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.